chr3-170998236-C-T
Variant names: 
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_000340.2(SLC2A2):c.1331G>A(p.Trp444*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Affects (★).
Frequency
 Genomes: not found (cov: 32) 
Consequence
 SLC2A2
NM_000340.2 stop_gained
NM_000340.2 stop_gained
Scores
 4
 2
 1
Clinical Significance
Conservation
 PhyloP100:  7.57  
Publications
0 publications found 
Genes affected
 SLC2A2  (HGNC:11006):  (solute carrier family 2 member 2) This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013] 
SLC2A2 Gene-Disease associations (from GenCC):
- glycogen storage disease due to GLUT2 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, G2P
- neonatal diabetes mellitusInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- permanent neonatal diabetes mellitusInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- transient neonatal diabetes mellitusInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region. 
PM2
Very rare variant in population databases, with high coverage; 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 33 
GnomAD4 exome 
Cov.: 
33
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Affects 
Submissions summary: Other:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Type 2 diabetes mellitus    Other:1 
Sep 08, 2017
Shenzhen Institute of Pediatrics, Shenzhen Children's Hospital
Significance:Affects
Review Status:criteria provided, single submitter
Collection Method:clinical testing
The patient carries a compound heterozygote mutation. The genotype:[c.1331G>A(p. Trp444*)]+[c.963+1G>A] -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Uncertain 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Uncertain 
D 
 PhyloP100 
 Vest4 
 GERP RS 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.